Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!
The research and development of new drugs is mainly divided into four stages: new drug discovery, preclinical research, clinical research and new drug application. Among them, the preclinical research of new drugs mainly uses animal disease models to study and evaluate the pharmacokinetics, pharmacodynamics and toxicology of drugs to ensure the effectiveness and safety of drugs. Preclinical research of new drugs can provide key data guidance for further clinical research of drugs, and provide a strong data basis for optimizing clinical development plan.
STEMart has advanced laboratory platform and professional technical team to provide comprehensive services for the preclinical research of new drugs, so as to provide technical support for the development of new drugs, and promote the drug application and marketing progress.
STEMart provides comprehensive drug safety research and evaluation services to ensure that new drugs comply with industry standards and regulations, laying the foundation for further clinical testing of drugs.
STEMart closely follows industry development and market demand, and is committed to providing timely and convenient pharmacodynamic research and evaluation services for drug research and development to accelerate the progress of customer research projects.
STEMart has a strong research and development team and rich industry experience, and can provide you with professional pharmacokinetic research and evaluation services to help promote the development process of new drugs.
STEMart can construct appropriate animal disease models for new drugs with different mechanisms of action, covering digestive system, respiratory system, cardiovascular system, nervous system, tumor animal models, etc.
For more information about our preclinical research services of new drugs, please contact us.